2012
DOI: 10.1016/j.bbrc.2011.12.032
|View full text |Cite
|
Sign up to set email alerts
|

MiR-19b-1 inhibits angiogenesis by blocking cell cycle progression of endothelial cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
34
0

Year Published

2012
2012
2019
2019

Publication Types

Select...
10

Relationship

3
7

Authors

Journals

citations
Cited by 50 publications
(36 citation statements)
references
References 26 publications
2
34
0
Order By: Relevance
“…In the present study, we demonstrated a significant correlation between the miR-17-92 cluster level and the proliferation, invasion and migration of osteosarcoma cells: the expression of miR-17-92 cluster was higher in cells with higher proliferation, invasion and migration potential. The positive association of miR-17-92 cluster with cell proliferation, invasion and migration suggests that miR-17-92 cluster may be categorized as a "metastasis promotor gene" in osteosarcoma, which was in line with previous reports [22,33,34].…”
Section: Discussionsupporting
confidence: 91%
“…In the present study, we demonstrated a significant correlation between the miR-17-92 cluster level and the proliferation, invasion and migration of osteosarcoma cells: the expression of miR-17-92 cluster was higher in cells with higher proliferation, invasion and migration potential. The positive association of miR-17-92 cluster with cell proliferation, invasion and migration suggests that miR-17-92 cluster may be categorized as a "metastasis promotor gene" in osteosarcoma, which was in line with previous reports [22,33,34].…”
Section: Discussionsupporting
confidence: 91%
“…MicroRNAs are now established therapeutically viable targets in the regulation of vascular inflammation and senescence (e.g., miR-146a, miR-217, miR-34a, miR-126, miR-21, miR-210, miR-181b) (121,151,169,170), tumor angiogenesis (miR-19b-1) (191), and in vascular diseases such as hypertension (miR-125a/b-5p) (83) and atherosclerosis (miR-92a, miR-27, miR-10a) (23, 46,47). In view of the established roles for TM in the regulation of inflammatory and thrombotic processes within the vascular wall, in conjunction with its indirect regulation by miR-92a via KLF2 (46,187), one can anticipate future studies detailing approaches to modulating TM levels in vivo using miRNA-targeting strategies.…”
Section: Posttranscriptional Regulationmentioning
confidence: 99%
“…However, there is some support for down-regulation of miRNA-31 in gastric cancer, and urothelial cancers (85)(86)(87)(88). Moreover a comparison of miRNAs and mRNA profiles of primary and metastatic cancer lesions showed that miRNAs provided a more reliable and distinctive signature than mRNAs and found that miRNA signatures were superior to mRNAs in identifying the organ source of meta stases of unknown origin (74,89 (92). Finally, it is possible that cellular miRNAs can create better conditions for the growth of the tumor.…”
Section: Cellular and Circulating Mirnas In Neoplastic Diseasesmentioning
confidence: 99%